Objective: To investigate the clinical value of serum or tissue placenta-specific 1(PLAC1) in the diagnosis of colon cancer and the judgment of lymph node metastasis risk. Methods: Bioinformatics analysis by downloading RNA-Seq expression data and patient clinical characteristics from the TCGA database in march 2021. From March 2018 to March 2021, 151 patients underwent resection of colon cancer and pathologically diagnosed colorectal cancer in our hospital were selected as the colon cancer group. Another 150 cases without any cancer were also selected into this study as the normal group. The expression of PLAC1 in colon cancer tissues or serum samples was analyzed by immunohistochemistry or ELISA. Results: The expression of PLAC1 in tumor tissue was significantly higher than that in normal tissue by bioinformatics analysis(P<0.01), and the high expression of PLAC1 was associated with distant metastasis, lymph node metastasis, clinical stage, total survival and disease-free survival(P<0.05). The positive expression rate of PLAC1 protein in tumor tissues was significantly higher than that in the para-cancerous normal tissues[64.90%(98/151) vs. 18.54%(28/151), P<0.05]. The serum PLAC1 level in the normal group and colon cancer group were 42.51(22.90,62.85) ng·ml-1 and 86.70(45.50,210.00) ng·ml-1,respectively. And the serum PLAC1 level in the colon cancer group was significantly higher than that in the normal group(P<0.05). In addition, high expression of PLAC1 of tissues was associated with tumor diameter >5 cm, lymph node metastasis and TNM Ⅲ~Ⅳ stage(P<0.05), and the serum PLAC1 level was associated with lymph node metastasis and TNM Ⅲ-Ⅳ stage(P<0.05). By ROC curve, the AUC of serum PLAC1 level for the diagnosis of colon cancer was 0.962(95%CI:0.934-0.989) and the AUC for the prediction of lymph node metastasis was 0.868(95%CI:0.828-0.908). Conclusion: The levels of PLAC1 in colon cancer tissues and serum are generally elevated, which are related to lymph node metastasis and disease progression. The detection of serum PLAC1 level can provide certain reference information for the diagnosis of colon cancer and prediction of lymph node metastasis risk. |
[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2018, 68(6):394-424.
[2] 高博, 陈卓妙语, 王秋生, 等.基于权重基因共表达分析的结肠癌肝转移相关基因挖掘与验证[J].中华结直肠疾病电子杂志, 2020, 8(4):363-369.
[3] YUAN H Y, WANG X Y, SHI C M, et al.Plac1 is a key regulator of the inflammatory response and immune tolerance in mammary tumorigenesis[J].Sci Rep, 2018, 8(1):5717.
[4] MAHMOUDIAN J, GHODS R, NAZARI M, et al.Expression profiling of plac1 in murine cancer cell lines[J].Exp Oncol, 2019, 41(1):7-13.
[5] 赵瑞, 李世拥, 安萍, 等.PLAC1在结直肠癌及其肝转移组织中的表达及临床意义[J].中华普外科手术学杂志(电子版), 2012, 6(3):281-285.
[6] 杜飞, 董亚萍, 朴成钢, 等.结肠癌靶向治疗的研究进展[J].生命的化学, 2018, 17(2):259-266.
[7] 邹小农, 贾漫漫, 王鑫, 等.《2020全球癌症报告》要点解读[J].中国胸心血管外科临床杂志, 2021, 28(1):11-18.
[8] 刘芳芳.结直肠癌免疫治疗的研究及前景展望[J].世界华人消化杂志, 2015, 28:4464-4472.
[9] MAHMOUDIAN J, GHODS R, NAZARI M, et al.PLAC1:biology and potential application in cancer immunotherapy[J].Cancer Immunol Immunother, 2019, 68(7):1039-1058.
[10] 李永飞.癌-睾丸抗原-PLAC1在乳腺癌侵袭转移中的作用及机制探讨[D].南京:南京医科大学, 2018.
[11] SILVA W A, GHJATIC S, RITTER E, et al.PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses[J].Cancer Immun, 2007, 7(11):18.
[12] YUAN H, CHEN V, BOISVERT M, et al.PLAC1 as a serum biomarker for breast cancer[J].PLoS One, 2018, 13(2):e0192106.
[13] LI Y, CHU J, LI J, et al.Cancer/testis antigen-Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway[J].Mol Oncol, 2018, 12(8):1233-1248.
[14] REN Y, LV Y X, LI T Y, et al.High expression of PLAC1 in colon cancer as a predictor of poor prognosis:a study based on TCGA data[J].Gene, 2020, 763(12):145072.
[15] JIAO T W, LI Y, GAO T, et al.MTA3 regulates malignant progression of colorectal cancer through Wnt signaling pathway[J].Tumour Biol, 2017, 39(3):1010428317695027.
[16] LAPORTE G A, LEGUISAMO N M, KALIL A N, et al.Clinical importance of DNA repair in sporadic colorectal cancer[J].Crit Rev Oncol Hematol, 2018, 126(7):168-185. |